Formulation And Evaluation Of Mouth Dissolving Tablets Of Amoxapine

Abstract

The objective of the present study is to design and formulate orodispersible tablets of Amoxapine using novel Co-processed superdisintegrants by employing direct compression method. Amoxapine is used to treat symptoms of depression. Amoxapine is a class II drug with high permeability and low solubility. There is a need to develop a formulation of Amoxapine that will enhance the bioavailability of the drug by decreasing the disintegration time.  Thus improves patient compliance generate rapid response enhances bioavailability and also reduces dose of drug. In this study ODTs are prepared by direct compression method using novel super disintigrants in different proportions .The powder blend is subjected to pre compression parameters including bulk density, true density, tapped density, cars index, Hausner’s ratio and angle of repose. The formulations are evaluated for weight variation, hardness, wetting time, water absorption test, disintegration time and in vitro dissolution studies and all formulations complies its Pharmacopoeial standards. The tablets are evaluated and the results compared for all four super disintigrants revealed cross povidone to be the most efficious super disintigrants to formulate mouth dissolving tablets of Naproxen sodium as suggested by the dispersion time , disintegration time and drug dissolution profiles